Innovation

New funding will support fundamental research into the molecular processes underlying human disorders such as Alzheimer’s and Parkinson’s diseases...

Europe's Graphene Flagship lays out a science and technology roadmap, targeting research areas designed to take graphene and related two-dimensional...

The European alternative finance market - which includes crowdfunding, peer-to-peer lending and invoice trading - reached €3 billion last year and...

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three...

Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society...

A new responsive material ‘glued’ together with short strands of DNA, and capable of translating thermal and chemical signals into visible physical...

An aircraft with a parallel hybrid engine – the first ever to be able to recharge its batteries in flight – has been successfully tested in the UK, an...

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has today become the first of new class of...

A flexible display incorporating graphene in its pixels’ electronics has been successfully demonstrated by the Cambridge Graphene Centre and Plastic...

University of Cambridge spin-out Reduse, which has developed a technology to remove print from paper allowing it to be reused several times before...